Dr Enrique Soto speaks to ecancer at the SIOG 2019 meeting in Geneva about the discussions from a breast cancer session looking at multidisciplinary views to the treatment of HER2 positive early breast cancer and triple negative early breast cancer in older adults.

He explains that it is important to increase the evidence base for treating older patients as older patients are often excluded form clinical trials meaning the information is often not there.

Dr Soto highlights that treatments should be tailored to the geriatric assessment and to the general needs of the patient.

This service has been kindly supported by unrestricted grants from Janssen Oncology and Sanofi Genzyme.